|
Filippi, M; Bozzali, M; Rovaris, M et al. (2003) Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain 126:433-7
|
|
Li, Belinda S Y; Regal, Juleiga; Soher, Brian J et al. (2003) Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 24:68-74
|
|
Bonneville, Fabrice; Moriarty, David M; Li, Belinda S Y et al. (2002) Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 23:371-5
|
|
Gonen, Oded; Moriarty, David M; Li, Belinda S Y et al. (2002) Relapsing-remitting multiple sclerosis and whole-brain N-acetylaspartate measurement: evidence for different clinical cohorts initial observations. Radiology 225:261-8
|
|
Li, Belinda S Y; Babb, James S; Soher, Brian J et al. (2002) Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 47:439-46
|
|
Li, B S; Regal, J; Gonen, O (2001) SNR versus resolution in 3D 1H MRS of the human brain at high magnetic fields. Magn Reson Med 46:1049-53
|
|
Movsas, B; Li, B S; Babb, J S et al. (2001) Quantifying radiation therapy-induced brain injury with whole-brain proton MR spectroscopy: initial observations. Radiology 221:327-31
|
|
Gonen, O; Gruber, S; Li, B S et al. (2001) Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison. AJNR Am J Neuroradiol 22:1727-31
|
|
Gonen, O; Grossman, R I (2000) The accuracy of whole brain N-acetylaspartate quantification. Magn Reson Imaging 18:1255-8
|
|
Gonen, O; Catalaa, I; Babb, J S et al. (2000) Total brain N-acetylaspartate: a new measure of disease load in MS. Neurology 54:15-9
|
Showing the most recent 10 out of 17 publications
